Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets ILS 1582.14 ILS 52.78 ILS 4750.47
  • Free AirMail shipping
60 tablets ILS 843.68 ILS 56.30 ILS 3378.06
  • Free AirMail shipping
30 tablets ILS 316.36 ILS 59.82 ILS 1794.51
  • Free AirMail shipping
20 tablets ILS 140.58 ILS 63.33 ILS 1266.66
  • Free AirMail shipping
10 tablets ILS 70.36 ILS 703.62
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets ILS 632.01 ILS 63.34 ILS 5700.60
  • Free AirMail shipping
60 tablets ILS 315.83 ILS 65.10 ILS 3905.91
  • Free AirMail shipping
30 tablets ILS 105.22 ILS 66.86 ILS 2005.65
  • Free AirMail shipping
20 tablets ILS 35.01 ILS 68.61 ILS 1372.23
  • Free AirMail shipping
10 tablets ILS 70.36 ILS 703.62
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets ILS 790.37 ILS 75.66 ILS 6809.09
  • Free AirMail shipping
60 tablets ILS 421.40 ILS 77.42 ILS 4644.90
  • Free AirMail shipping
30 tablets ILS 158.00 ILS 79.17 ILS 2375.15
  • Free AirMail shipping
20 tablets ILS 70.20 ILS 80.93 ILS 1618.56
  • Free AirMail shipping
10 tablets ILS 84.44 ILS 844.38
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.